People · Operator
Named in public records as an officer, director or promoter · active 2008–2024 · Biotechnology, Other, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2008 |
| Nxthera Inc | — | Other | Series B | $87.1M | $342.4M | 2009 |
| Francis Medical, Inc. | — | Healthtech | Series B | $70.1M | $233.8M | 2018 |
| Aegea Medical Inc | — | Other Health Care | Series A | $23.4M | $121.1M | 2011 |
Michael Hoey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Hoey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jan Garfinkle | 2 | 7 |
| Andre De Bruin | 2 | 2 |
| John Brooks | 1 | 8 |
| Eric Kim | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| David Adair | 1 | 7 |
| Sami Hamade | 1 | 6 |
| Andrew Cleeland | 1 | 5 |
| David Douglass | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| J. ROBERT PAULSON | 1 | 4 |
| Carl Simpson | 1 | 4 |
| DOUG KELLY | 1 | 4 |
| Charles Carignan | 1 | 3 |
| J.C. MacRae | 1 | 3 |
| Douglas Kelly | 1 | 3 |
| John Beck | 1 | 3 |
| Casey McGlynn | 1 | 3 |
| R. King Nelson | 1 | 2 |
| Carmen L Bringgold | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.